• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Steven Romano - Articles and news items

Pfizer logo

Pfizer announces positive top-line results from Phase 3 study of NONACOG ALFA (BeneFIX®) once-weekly prophylaxis for hemophilia B

Industry news / 17 July 2014 / Pfizer

Pfizer Inc. announced the positive results of a Phase 3 study comparing a prophylaxis regimen of BeneFIX® Coagulation Factor IX (Recombinant) 100 IU/kg once-weekly to on-demand treatment in people with moderately severe to severe hemophilia B…

Pfizer logo

Pfizer announces positive top-line results from two Phase 3 trials of Tofacitinib in adults with moderate-to-severe chronic plaque psoriasis

Industry news / 23 April 2014 / Pfizer

Pfizer Inc. announced top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079)…

Pfizer logo
Pfizer logo

Pfizer announces top-line efficacy results from a Phase 4 study of PRISTIQ® (desvenlafaxine)

Industry news, News / 24 January 2013 / Pfizer

New data add to evidence supporting PRISTIQ as a treatment option for MDD…

Pfizer logo
Pfizer logo
Pfizer logo

Pfizer announces top-line results from a Phase 3 long-term safety study of ALO-02

Industry news, News / 11 October 2012 / Pfizer

“These top-line data provide evidence of the long-term safety of ALO-02…”

Pfizer logo

Pfizer announces co-primary clinical endpoints not met in second Phase 3 Bapineuzumab Study

Industry news, News / 6 August 2012 / Pfizer

Bapineuzumab IV Phase 3 program discontinued…

Pfizer logo

Topline results of first of four studies in bapineuzumab Phase 3 program

Industry news, News / 23 July 2012 / Pfizer

Co-primary clinical endpoints not met in study of patients with Alzheimer’s disease who carry the ApoE4 genotype…

Pfizer logo

European Medicines Agency accepts regulatory submission for bazedoxifene/conjugated estrogens

Industry news, News / 19 July 2012 / Pfizer

The EMA has accepted for review the MAA for bazedoxifene/conjugated estrogens…

Pfizer logo
Pfizer logo

Pfizer stops Phase 3 trial Of Lyrica (pregabalin) capsules CV in neuropathic pain associated with HIV neuropathy

Industry news, News / 4 May 2012 / Pfizer

Pfizer has stopped a Phase 3 clinical trial of Lyrica in patients with neuropathic pain…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +